3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
5
Small Cell Lung Carcinoma
5
Stomach Neoplasms
4
Neuroblastoma
4
Fallopian Tube Neoplasms
4
Urinary Bladder Neoplasms
3
Ovarian Neoplasms
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Gallbladder Neoplasms
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Urethral Neoplasms
2
Ureteral Neoplasms
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Hepatocellular
2
Brenner Tumor
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solid Neoplasms
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrent Uterine Corpus Carcinoma
1
Interventions
pembrolizumab
2
Platinum
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Solid Neoplasms
×
Platinum
×
Clear all
NCT04420884
2026-04-08
iintune-1
Takeda
Phase 1/2
Completed
248 enrolled